0000904454-17-000101.txt : 20170206 0000904454-17-000101.hdr.sgml : 20170206 20170206191650 ACCESSION NUMBER: 0000904454-17-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170202 FILED AS OF DATE: 20170206 DATE AS OF CHANGE: 20170206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 807-6600 MAIL ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc DATE OF NAME CHANGE: 20090130 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peterson Kristine CENTRAL INDEX KEY: 0001508596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36066 FILM NUMBER: 17576830 MAIL ADDRESS: STREET 1: AMARIN CORPORATION STREET 2: MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE CITY: MYSTIC STATE: CT ZIP: 06355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-02-02 0001178711 Paratek Pharmaceuticals, Inc. PRTK 0001508596 Peterson Kristine C/O PARATEK PHARMACEUTICALS, INC. 75 PARK PLAZA, 4TH FLOOR BOSTON MA 02116 1 0 0 0 Common Stock 2017-02-02 4 A 0 6000 0 A 6000 D Stock Option (right to buy) 15.10 2017-02-02 4 A 0 6000 0 A 2027-02-01 Common Stock 6000 6000 D The shares shall vest on the one-year anniversary of February 2, 2017, subject to the Reporting Person's continued service to the Company at the vesting date. The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant. The shares shall vest as to 1/12 of the shares on the one-month anniversary following February 2, 2017, and on the same calendar date of each successive month thereafter until fully vested, subject to the Reporting Person's continued service to the Company at each vesting date. /s/ William M. Haskel, Attorney-in-Fact for Kristine Peterson 2017-02-06